Literature DB >> 27037256

Afatinib + Cetuximab First-line in EGFR-Mutant Lung Cancer--Letter.

Alexis B Cortot1, Denis Moro-Sibilot2, Jacques Cadranel3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27037256     DOI： 10.1158/1078-0432.CCR-15-2824

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  2 in total

1.  Osimertinib in first-line treatment-is a comparison not proof?

Authors:  Jacques Cadranel
Journal:  Ann Transl Med       Date:  2018-02

Review 2.  Local ablative therapy in oncogenic-driven oligometastatic non-small cell lung cancer: present and ongoing strategies-a narrative review.

Authors:  Vincent Fallet; Lise Matton; Antoine Schernberg; Anthony Canellas; François H Cornelis; Jacques Cadranel
Journal:  Transl Lung Cancer Res       Date:  2021-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.